Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Del Labs

This article was originally published in The Tan Sheet

Executive Summary

Orajel and cosmetics drove up net sales 20.2% to $77.7 mil. for the third quarter, company says Oct. 26. Net income for the quarter was $1.2 mil., compared to a $6.1 mil. loss in the year-ago period. Nine-month sales totaled $221.7 mil., a 12.6% increase from the prior-year period. Ads for Orajel Ultra Mouth Sore Medicine, which shipped at the end of the quarter, are slated for February 2001 (1"The Tan Sheet" Oct. 9, p. 5)
Advertisement

Related Content

Orajel Ultra Mouth Sore "Film-Forming Gel" TV Ads Slated For February
Orajel Ultra Mouth Sore "Film-Forming Gel" TV Ads Slated For February

Topics

Advertisement
UsernamePublicRestriction

Register

PS091851

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel